(Q34055089)

English

Differential sensitivity to platinum-based chemotherapy in primary uterine serous papillary carcinoma cell lines with high vs low HER-2/neu expression in vitro

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Differential sensitivity to platinum-based chemotherapy in primary uterine serous papillary carcinoma cell lines with high vs low HER-2/neu expression in vitro (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

papillary carcinoma

1 reference

based on heuristic

inferred from title

author name string

Sarah N Cross

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Emiliano Cocco

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Stefania Bellone

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Valsamo K Anagnostou

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Stacey L Brower

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Christine E Richter

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Eric R Siegel

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Peter E Schwartz

8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Thomas J Rutherford

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Alessandro D Santin

10

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

24 April 2010

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

American Journal of Obstetrics and Gynecology

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

203

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

162.e1-8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918912

5 July 2018

Cancer statistics, 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918912

5 July 2018

The ChemoFx assay: an ex vivo chemosensitivity and resistance assay for predicting patient response to cancer chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918912

5 July 2018

An exploratory analysis of HER-2 amplification and overexpression in advanced endometrial carcinoma: a Gynecologic Oncology Group study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918912

5 July 2018

The management of serous papillary uterine cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918912

5 July 2018

Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): a major prognostic indicator in uterine serous papillary cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918912

5 July 2018

Untangling the ErbB signalling network

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918912

5 July 2018

The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918912

5 July 2018

Endometrial papillary serous carcinoma: patterns of spread and treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918912

5 July 2018

Enhanced chemoresistance by elevation of p185neu levels in HER-2/neu-transfected human lung cancer cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918912

5 July 2018

Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918912

5 July 2018

Two pathogenetic types of endometrial carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918912

5 July 2018

Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918912

5 July 2018

Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918912

5 July 2018

Prediction of chemosensitivity using multigene analysis in head and neck squamous cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918912

28 October 2018

Amplification of c-erbB2 oncogene: a major prognostic indicator in uterine serous papillary carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918912

28 October 2018

Determination of HER2/neu status in uterine serous papillary carcinoma: Comparative analysis of immunohistochemistry and fluorescence in situ hybridization.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918912

28 October 2018

Correlation of intrinsic chemoresistance of non-small-cell lung cancer cell lines with HER-2/neu gene expression but not with ras gene mutations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918912

28 October 2018

Clinical significance of Her-2/neu overexpression in uterine serous carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20417484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progression-free interval in ovarian cancer and predictive value of an ex vivo chemoresponse assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/20417484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER-2 is an independent prognostic factor in endometrial cancer: association with outcome in a large cohort of surgically staged patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20417484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER-2/neu expression: a major prognostic factor in endometrial cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20417484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of c-erbB2 overexpression on the drug sensitivities of normal human mammary epithelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/20417484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Her-2/neu overexpression and amplification in uterine papillary serous carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20417484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20417484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.AJOG.2010.02.056

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34055089&oldid=1538703098"